Log in

Start free trial
Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Capital-lir 5 Inside the Lab Industry: Cancer Genetics Wants to Take the Biopsy Out of Oncology Diagnoses

Inside the Lab Industry: Cancer Genetics Wants to Take the Biopsy Out of Oncology Diagnoses

by | Feb 24, 2015 | Capital-lir, Fee Schedules-lir, Inside the Lab Industry-lir, Laboratory Industry Report, Reimbursement-lir | 0 comments

Although growing fast, Cancer Genetics Inc. is currently about one-thousandth the size of LabCorp and Quest Diagnostics. While it lacks the heft of those two leading national players, the New Jersey-based Cancer Genetics does have some things those much larger labs do not: a burgeoning joint venture with the Mayo Clinic and rapidly growing revenues. […]

Although growing fast, Cancer Genetics Inc. is currently about one-thousandth the size of LabCorp and Quest Diagnostics. While it lacks the heft of those two leading national players, the New Jersey-based Cancer Genetics does have some things those much larger labs do not: a burgeoning joint venture with the Mayo Clinic and rapidly growing revenues….

This content is for Paid Members only.
Login Register